TransLvTM Lentivirus Precipitation Solution (5×)
慢病毒浓缩试剂
目录号： FV101-01
单 价：￥2420
产品详情介绍
TransLvTM Lentivirus Precipitation Solution是一种简单、快速、高效的慢病毒浓缩试剂。使用该浓缩试剂无需超速离心操作，只需将慢病毒上清液与浓缩试剂简单混合孵育，常规离心后，即可获得浓缩的慢病毒颗粒，整个过程可在90分钟内完成，慢病毒颗粒回收率可达到90%，滴度最高可提高约100倍。
慢病毒滴度检测介绍视频
Luo Y, Liu S, Xue J, et al. High-throughput screening of spike variants uncovers the key residues that alter the affinity and antigenicity of SARS-CoV-2[J]. Cell Discovery, 2023.(IF 33.50)
Wang J, Zhu Y, He X, et al. Targeting non-canonical antigens unlocks functional T-cell responses in renal cell carcinoma[J]. Journal for Immunotherapy of Cancer, 2026.(IF 11.70)
Yao P, Gao M, Hu W, et al. Proteogenomic analysis identifies neoantigens and bacterial peptides as immunotherapy targets in colorectal cancer[J]. Pharmacological Research, 2024.(IF 9.10)
Sennikov S, Volynets M, Alrhmoun S, et al. Modified Dendritic cell-based T-cell expansion protocol and single-cell multi-omics allow for the selection of the most expanded and in vitro-effective clonotype via profiling of thousands of MAGE-A3-specific T-cells[J]. Frontiers in Immunology, 2024.(IF 5.70)
Wang W, Wang M, Du T, et al. SHMT2 promotes gastric cancer development through regulation of HIF1α/VEGF/STAT3 signaling[J]. International journal of molecular sciences, 2023.(IF 5.60)
Alrhmoun S, Fisher M, Lopatnikova J, et al. Targeting precision in cancer immunotherapy: naturally-occurring antigen-specific TCR discovery with single-cell sequencing[J]. Cancers, 2024.(IF 4.50)
